Pharmacokinetics of Ciprofloxacin in Liver Cirrhosis | Citedby Results | Chemotherapy | Karger Publishers

Skip to Main Content

Skip Nav Destination

Pharmacokinetics of Ciprofloxacin in Liver Cirrhosis

Chemotherapy (1990) 36 (6): 385–391.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life

Jan-Frederik Schlender
Donato Teutonico
Katrin Coboeken
Katrin Schnizler
Thomas Eissing
Stefan Willmann
Ulrich Jaehde
Heino Stass

Clinical Pharmacokinetics (2018) 57 (12): 1613.

Pharmacokinetic and Pharmacodynamic Aspects of Antibiotic Use in High-Risk Populations

Scott J. Bergman
Cristian Speil
Michael Short
Janak Koirala

Infectious Disease Clinics of North America (2007) 21 (3): 821.

Human variability in the renal elimination of foreign compounds and renal excretion-related uncertainty factors for risk assessment

J.L.C.M. Dorne
K. Walton
A.G. Renwick

Food and Chemical Toxicology (2004) 42 (2): 275.

Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid

Helen Sambatakou
Evangelos J. Giamarellos-Bourboulis
Nearchos Galanakis
Helen Giamarellou

International Journal of Antimicrobial Agents (2001) 18 (5): 441.

Antibiotic treatment in patients with altered pathophysiolocical pathways

P. Altucci
G. Abbate
S. Esposito

Archives of Gerontology and Geriatrics (1996) 22: 429.

Variable Disposition of Ciprofloxacin in Critically Ill Patients Undergoing Continuous Arteriovenous Hemodiafiltration

Douglas N. Fish
Jacquelyn L. Bainbridge
Charles A. Peloquin

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (1995) 15 (2): 236.

Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: A review

Fritz Sörgel
Kurt G. Naber
Martina Kinzig
Gerhard Mahr
Peter Muth

The American Journal of Medicine (1991) 91 (6): S51.